Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
<1m ago BH MACRO : Transaction in Own Shares
<1m ago EU launches WTO dispute to challenge new Boeing subsidies
<1m ago FREEDOM PETROLEUM : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
1m ago IMF MONETARY FUND : Press Release: IMF Executive Board Discusses Reform of the Policy on Public Debt Limits in Fund-Supported Programs
1m ago STATE BANK OF INDIA : Market Movers - Top risers and fallers at 16:00
1m ago NIKE : Masterpiece Melange: KOBE 9 Elite What The
2m ago Fitch Rates Tortoise Energy Infrastructure Notes 'AAA'; Affirms Existing Ratings
2m ago EU launches WTO dispute to challenge new Boeing subsidies
5m ago San Francisco Dentists at CitiDent are Now Offering a Special Promotion for New Patients
5m ago ASPEN INSURANCE : Re Renews Silverton for 2015
Latest news
Advertisement
Hot News 
DIXONS CARPHONE : *exane bnp raises dixons carphone price target to 510 (450) pence - 'outperform'
BERKELEY MINERAL RESOURCES : Obsidian IR
ATLANTIS RESOURCES : Makes First MeyGen Facility Drawdown
E THERAPEUTICS' : Impact is rated World Class
FINISH LINE : Reports Third Quarter Fiscal Year 2015 Results
Most Read News
1d ago Wall St. has best second-day gain since 2011 on Fed optimism
1d agoDJKEPPEL LAND : Correction to Keppel Land to Buy 75% Stake in Array Article (on Friday)
1d ago WELLS FARGO : exec Petrilla is new head of state's California-China trade office
1d ago Unilever drops mayonnaise suit against Just Mayo maker
1d ago Brazil's Rousseff vows clean-up of scandal-tainted Petrobras
Most recommended articles
<1m ago BOEING : EU launches WTO dispute to challenge new Boeing subsidies
8m ago Euro Struggles Ahead of Greek Election- USD/CAD Carves Lower Highs
9m agoDJLONDON MARKETS : U.K. Stocks Log Best Week In Three Years; Next Shares Fall
17m ago Full text of U.S. FBI statement on Sony cyberattack
21m ago Oil up on pre-holiday short-covering but down for fourth week
Dynamic quotes  
ON
| OFF